Search results for "Santé Publique"

showing 10 items of 286 documents

Association between food insecurity and depression among older adults from low- and middle-income countries.

2021

Background:\ud \ud To examine the association between self‐reported food insecurity and depression in 34,129 individuals aged ≥50 years from six low‐ and middle‐income countries (LMICs) (China, Ghana, India, Mexico, Russia, and South Africa).\ud \ud Methods:\ud \ud Cross‐sectional, community‐based, nationally representative data from the WHO Study on global AGEing and adult health (SAGE) were analyzed. Self‐reported past 12‐month food insecurity was assessed with two questions on frequency of eating less and hunger due to lack of food. Questions based on the World Mental Health Survey version of the Composite International Diagnostic Interview were used for the endorsement of past 12‐month …

MaleChinaPsychological interventionIndiaLogistic regressionGhanaOddsRussia03 medical and health sciencesSouth Africa0302 clinical medicineolder adults.Environmental healthfood insecurityPrevalenceMedicineHumanslow- and middle-income countriesAssociation (psychology)Developing CountriesMexicoDepression (differential diagnoses)older adultsAged2. Zero hungerbusiness.industry1. No povertyMiddle Aged*low- and middle-income countriesMental healthConfidence interval3. Good health030227 psychiatryFood insecurityPsychiatry and Mental healthClinical PsychologyCross-Sectional Studieslow- and middle-income countriedepressionFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie*food insecuritybusiness*older adultsSmith L. Il Shin J. McDermott D. Jacob L. Barnett Y. López-Sánchez G. F. Veronese N. Yang L. Soysal P. Oh H. et al. -Association between food insecurity and depression among older adults from low- and middle-income countries.- Depression and anxiety 2021030217 neurology & neurosurgery*depression
researchProduct

Burnout, associated comorbidities and coping strategies in French community pharmacies—BOP study: A nationwide cross-sectional study

2016

International audience; Background: work-related stress and burnout syndromes are unfortunately common comorbidities found in health professionals. However, burnout syndrome has only been partly and episodically assessed for community pharmacists whereas these professionals are exposed to patients’ demands and difficulties every day. Prevalence of burnout, associated comorbidities and coping strategies were assessed in pharmacy teams (pharmacists and pharmacy technicians) in French community pharmacies.Methods: This online survey was performed by emails sent to all French community pharmacies over 3 months. The survey assessed the prevalence of burnout (Maslach Burnout Inventory—MBI—questio…

MaleCoping (psychology)Cross-sectional studyhealth care facilities manpower and services[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthEmotionsPharmacy TechniciansSocial Scienceslcsh:MedicineAlcohol abuseComorbidityAnxietyBurnoutPharmacists030226 pharmacology & pharmacy0302 clinical medicineSurveys and QuestionnairesAdaptation PsychologicalPrevalenceMedicine and Health SciencesPsychologyAlcohol consumption030212 general & internal medicinelcsh:ScienceBurnout ProfessionalMultidisciplinaryDepressionMiddle AgedPharmacologic stress testingSports Science3. Good healthProfessionsWorkforceWorkforceAnxietyFemaleFrancemedicine.symptompsychological phenomena and processesResearch ArticleAdultmedicine.medical_specialtyAlcohol DrinkingeducationPharmacy03 medical and health scienceshealth services administrationMental Health and PsychiatrymedicineHumansNutritionPharmaciesPharmacologyMood Disordersbusiness.industrylcsh:RBiology and Life SciencesTechniciansmedicine.diseaseComorbidityDietPharmacologic-Based DiagnosticsCross-Sectional StudiesPsychological stress[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthFamily medicinePeople and PlacesPopulation Groupingslcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieSports and exercise medicinebusinessStress PsychologicalAnxiolyticsPLOS ONE
researchProduct

Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in …

2013

International audience; We evaluated the impact of cytomegalovirus (CMV)-induced immune responses, autoimmune-induced immune responses, and microbial translocation on immune activation in 191 human immunodeficiency virus type 1-infected patients from the ANRS CO3 Aquitaine Cohort. All enrolled subjects had achieved long-term virological suppression during receipt of combination antiretroviral therapy (cART). HLA-DR(+)/CD38(+) expression was 16.8% among CD8(+) T cells. Independent of age, CD4(+) T-cell count, 16S ribosomal DNA load, and regulatory T-cell count, positive results of Quantiferon CMV analysis (P = .02), positive results of CMV-pp65 enzyme-linked immunosorbent spot analysis (P = …

MaleCytomegalovirusAutoimmunityHIV InfectionsCD8-Positive T-LymphocytesCD38Lymphocyte Activationmedicine.disease_causeAutoimmunityCohort Studies0302 clinical medicine[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases[ SDV.MP ] Life Sciences [q-bio]/Microbiology and ParasitologyAntiretroviral Therapy Highly ActiveImmunology and Allergy030212 general & internal medicineMESH: Cytomegalovirus Infections/immunologyMESH: HLA-DR Antigens/metabolismMESH: Cohort Studies0303 health sciencesMESH: HIV Infections/drug therapyvirus diseasesViral Load3. Good healthInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMESH: CD8-Positive T-Lymphocytes/immunologyCytomegalovirus Infections[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases[SDV.IMM]Life Sciences [q-bio]/ImmunologyFemaleFranceMESH: Cytomegalovirus/immunologyMESH: Viral Load[SDV.IMM] Life Sciences [q-bio]/ImmunologyCongenital cytomegalovirus infectionHuman leukocyte antigenBiologyQuantiFERONViral Matrix Proteins03 medical and health sciencesImmune systemMESH: Cross-Sectional StudiesAntigenMESH: AutoimmunitymedicineHumansMESH: Phosphoproteins/immunology[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyMESH: Viral Matrix Proteins/immunology030304 developmental biologyMESH: HumansMESH: HIV-1/geneticsMESH: HIV-1/physiologyMESH: HIV Infections/immunologyHLA-DR AntigensPhosphoproteinsmedicine.diseaseVirologyMESH: MaleMESH: Lymphocyte Activation/immunologyMESH: FranceCross-Sectional Studies[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieImmunologyHIV-1[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieMESH: HIV-1/drug effectsMESH: FemaleCD8
researchProduct

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabin…

2019

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. At week 52 participants in the boosted PI arm were offered switch to D/C/F/TAF (late-switch, 44 weeks D/C/F/TAF exposure). All participants were followed on D/C/F/TAF until week 96. Efficacy endpoints were percentage cumulative protocol-defined virologic rebound (PDVR; confirmed vira…

MaleDOLUTEGRAVIRSustained Virologic ResponseHIV InfectionsGastroenterologychemistry.chemical_compound0302 clinical medicineMedicine and Health SciencesEmtricitabine030212 general & internal medicinePharmacology & PharmacyDarunavir0303 health sciencesAlanineDrug SubstitutionCobicistatEmtricitabine Tenofovir Disoproxil Fumarate Drug CombinationLamivudineAntiretroviralsMiddle AgedViral LoadOPEN-LABEL3. Good healthWEIGHT-GAINDrug CombinationsTreatment OutcomeDolutegravirNON-INFERIORITYFemaleSafetyViral loadLife Sciences & Biomedicinemedicine.drugTabletsAdultmedicine.medical_specialtyEfficacyAnti-HIV AgentsRITONAVIREmtricitabineTENOFOVIR ALAFENAMIDELAMIVUDINETenofovir alafenamideSingle-tablet regimen03 medical and health sciencesInternal medicineVirologymedicineVIH (Virus)HumansSwitch studyProtease InhibitorsTenofovirDarunavirAgedPharmacologyScience & Technology030306 microbiologybusiness.industryHIV (Viruses)AdenineDarunavir/cobicistat/emtricitabine/TAFAntiretroviral agentsCOBICISTATMAINTENANCEchemistry[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieHIV-1RitonavirCobicistat[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessRESISTANCE
researchProduct

Comparison of Epithor clinical national database and medico-administrative database to identify the influence of case-mix on the estimation of hospit…

2019

BackgroundThe national Epithor database was initiated in 2003 in France. Fifteen years on, a quality assessment of the recorded data seemed necessary. This study examines the completeness of the data recorded in Epithor through a comparison with the French PMSI database, which is the national medico-administrative reference database. The aim of this study was to demonstrate the influence of data quality with respect to identifying 30-day mortality hospital outliers.MethodsWe used each hospital's individual FINESS code to compare the number of pulmonary resections and deaths recorded in Epithor to the figures found in the PMSI. Centers were classified into either the good-quality data (GQD) …

MaleDatabases FactualOutliers DRGPulmonologyCancer Treatment030204 cardiovascular system & hematologyLogistic regressionHealth administration0302 clinical medicineHospital AdministrationInterquartile rangeMedicine and Health SciencesMedicineHospital MortalityRespiratory System ProceduresMultidisciplinaryMortality rateQRRegression analysisHospitals3. Good healthSurgical OncologyOncologyMedicineFemaleRisk AdjustmentLung ResectionResearch ArticleClinical OncologyDeath RatesScienceSurgical and Invasive Medical Procedures03 medical and health sciencesCase mix indexPopulation MetricsHumansDiagnosis-Related GroupsPopulation BiologySurgical Resectionbusiness.industryBiology and Life SciencesModels TheoreticalHealth CareStandardized mortality ratioLogistic ModelsDyspnea030228 respiratory systemHealth Care Facilities[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieData quality[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieClinical MedicinebusinessDemography
researchProduct

Medical pre-hospital management reduces mortality in severe blunt trauma: a prospective epidemiological study

2011

International audience; INTRODUCTION: Severe blunt trauma is a leading cause of premature death and handicap. However, the benefit for the patient of pre-hospital management by emergency physicians remains controversial because it may delay admission to hospital. This study aimed to compare the impact of medical pre-hospital management performed by SMUR (Service Mobile d'Urgences et de Réanimation) with non-medical pre-hospital management provided by fire brigades (non-SMUR) on 30-day mortality. METHODS: The FIRST (French Intensive care Recorded in Severe Trauma) study is a multicenter cohort study on consecutive patients with severe blunt trauma requiring admission to university hospital i…

MaleEmergency Medical ServicesTime FactorsMESH : AgedMESH : Prospective StudiesPoison controlCritical Care and Intensive Care Medicine0302 clinical medicineInjury Severity ScorePatient AdmissionEmergency medical services[ SHS.INFO ] Humanities and Social Sciences/Library and information sciences030212 general & internal medicineHospital MortalityProspective StudiesProspective cohort studyMESH: Treatment OutcomeMESH: AgedMESH: Middle AgedMortality rate[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieMESH : Patient AdmissionMESH : AdultMiddle Aged3. Good healthMESH : Wounds and InjuriesIntensive Care UnitsTreatment OutcomeBlunt traumaMESH: Young AdultBlunt traumaMESH: Emergency Medical ServicesInjury Severity ScoreMESH : Injury Severity ScoreFranceMESH: FirefightersMESH : Intensive Care UnitsCohort studyMESH : Time FactorsAdultmedicine.medical_specialtyAdolescentMESH : Male[SHS.INFO]Humanities and Social Sciences/Library and information sciencesMESH: Injury Severity ScoreMESH : Young AdultMESH : Treatment Outcome[SHS.INFO] Humanities and Social Sciences/Library and information sciencesMESH : Hospital Mortality03 medical and health sciencesYoung AdultIntensive careMESH : AdolescentmedicineHumansMESH : Emergency Medical ServicesMESH : Middle AgedMESH: Hospital MortalityIntensive care medicineMESH : FranceAgedMESH: AdolescentMESH: Humansbusiness.industryMESH: Patient AdmissionResearchMESH : HumansMESH: Time Factors030208 emergency & critical care medicineMESH: AdultMESH: MaleMESH: Prospective StudiesMESH: France[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieMESH: Wounds and InjuriesFirefightersEmergency medicineWounds and InjuriesMESH: Intensive Care Units[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieMESH : FirefightersbusinessCritical Care
researchProduct

Prenatal and postnatal exposure to persistent organic pollutants and attention-deficit and hyperactivity disorder: a pooled analysis of seven Europea…

2018

International audience; Background - Attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide for reasons largely unknown and environmental chemicals with neurotoxic properties, such as persistent organic pollutants (POPs), have been proposed to play a role. We investigated the association between prenatal and postnatal exposure to polychlorinated biphenyl-153 (PCB-153), p-p´-dichlorodiphenyldichloroethylene (p-p'-DDE) and hexachlorobenzene (HCB) and ADHD in childhood. Methods - We pooled seven European birth cohort studies encompassing 4437 mother-child pairs from the general population with concentrations of PCB-153, p-p´-DDE and HCB measured in cord blood, maternal blood o…

MaleEpidemiology010501 environmental sciences01 natural sciencesCohort Studies0302 clinical medicinePregnancyHexachlorobenzeneChildeducation.field_of_studyPerinatal ExposureGeneral MedicineEnvironmental exposureFetal BloodPolychlorinated Biphenyls3. Good healthEuropeMaternal ExposureChild PreschoolPrenatal Exposure Delayed EffectsEnvironmental PollutantsFemaleCohort studyAdolescentpolychlorinated biphenylsDichlorodiphenyl DichloroethylenePopulationPrenatal careattention-deficit disorder with hyperactivityDDT03 medical and health sciencesmedicineAttention deficit hyperactivity disorderHumanseducationPrenatal Exposures to Pollutants0105 earth and related environmental sciencesPregnancybusiness.industryOdds ratioEnvironmental Exposuremedicine.diseaseLogistic Modelshexachlorobenzene[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieAttention Deficit Disorder with Hyperactivity[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusiness030217 neurology & neurosurgeryDemography
researchProduct

Relationship between childhood physical abuse and clinical severity of treatment-resistant depression in a geriatric population

2021

Introduction We assessed the correlation between childhood maltreatment (CM) and severity of depression in an elderly unipolar Treatment-Resistant Depression (TRD) sample. Methods Patients were enrolled from a longitudinal cohort (FACE-DR) of the French Network of Expert TRD Centres. Results Our sample included 96 patients (33% of the overall cohort) aged 60 years or above, with a mean age of 67.2 (SD = 5.7). The majority of the patients were female (62.5%). The Montgomery and Asberg Depression Rating Scale (MADRS) and Quick Inventory Depression Scale-Self Report (QIDS-SR) mean scores were high, 28.2 (SD = 7.49) [MADRS score range: 0–60; moderate severity≥20, high severity≥35] and 16.5 (SD…

MaleEpidemiologyEmotionsSocial SciencesCriminologyPediatricsSeverity of Illness IndexGeriatric DepressionDepressive Disorder Treatment-Resistant0302 clinical medicineSociologyAdverse Childhood ExperiencesMedicine and Health SciencesPsychologyPublic and Occupational HealthChild AbuseDepression (differential diagnoses)Aged 80 and overeducation.field_of_studySchoolsMultidisciplinaryDepression[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyTraumatic Injury Risk FactorsQRMiddle AgedPhysical abuseCohortMedicineFemaleCrimeFranceResearch ArticlePersonalitymedicine.medical_specialtyPsychometricsScienceGeriatric PsychiatryPopulationEducation03 medical and health sciencesRating scaleGeriatric populationInternal medicineMental Health and PsychiatrymedicineHumanseducationAgedPersonality TraitsPsychiatric Status Rating ScalesDepressive Disorder MajorMood Disordersbusiness.industryCTQ treeBiology and Life Sciencesmedicine.disease030227 psychiatryHealth CareGeriatricsMedical Risk Factors[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieGeriatric CareSelf ReportbusinessTreatment-resistant depression030217 neurology & neurosurgery
researchProduct

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

2023

Abstract Background We describe demographic features, treatments and clinical outcomes in the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) COVID-19 cohort, one of the world's largest international, standardized data sets concerning hospitalized patients. Methods The data set analysed includes COVID-19 patients hospitalized between January 2020 and January 2022 in 52 countries. We investigated how symptoms on admission, co-morbidities, risk factors and treatments varied by age, sex and other characteristics. We used Cox regression models to investigate associations between demographics, symptoms, co-morbidities and other factors with risk of death, admiss…

MaleEpidemiologyMESH: HospitalizationMESH: Proportional Hazards ModelsMESH: Risk FactorsRisk FactorsMESH: Childcohort studyMESH: COVID-19HumansMESH: SARS-CoV-2ChildProportional Hazards ModelsMESH: HumansMESH: Middle AgedSARS-CoV-2COVID-19risk of deathGeneral MedicineMiddle AgedCOVID-19; SARS-CoV-2; co-morbidities; cohort study; risk of death; symptoms; treatmentsMESH: MaleHospitalizationIntensive Care Unitsco-morbiditiestreatmentssymptomsMESH: Intensive Care Units[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCOVID-19/therapy
researchProduct

Does low to moderate environmental exposure to noise and air pollution influence preterm delivery in medium-sized cities?

2017

International audience; Background: Preterm birth (PB) is an important predictor of childhood morbidity and educational performance. Beyond the known risk factors, environmental factors, such as air pollution and noise, have been implicated in PB. In urban areas, these pollutants coexist. Very few studies have examined the effects of multi-exposure on the pregnancy duration. The objective of this study was to analyse the relationship between PB and environmental chronic multi-exposure to noise and air pollution in medium-sized cities.Methods: A case-control study was conducted among women living in the city of Besançon (121 671 inhabitants) or in the urban unit of Dijon (243 936 inhabitants…

MaleEpidemiologyair pollutionAir pollutionenvironmental exposure010501 environmental sciencesmedicine.disease_cause01 natural sciences[ SHS.GEO ] Humanities and Social Sciences/Geography0302 clinical medicinePregnancyRisk Factors11. SustainabilityMedicine030212 general & internal medicinemedia_commonGeneral MedicineEnvironmental exposure[SHS.GEO]Humanities and Social Sciences/Geography3. Good healthPremature birthPremature BirthFemaleFranceAdultPollutionnoisemedia_common.quotation_subjectcase-control studyNitrogen DioxideGestation period[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetricsYoung Adult03 medical and health sciencesEnvironmental healthHumansCities0105 earth and related environmental sciences[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/Healthbusiness.industryNoise pollutionInfant Newbornpreterm birthOdds ratiomedicine.diseaseNoiseLogistic Models13. Climate actionCase-Control Studies[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusiness
researchProduct